SGI
GSK icon

Summit Global Investments’s GSK GSK Stock Holding History

Summit Global Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
20,852
+5,848
+39% +$309K 0.06% 189
2026
Q1 		$828K Buy
15,004
+3,364
+29% +$182K 0.05% 225
2025
Q4 		$571K Buy
+11,640
New +$543K 0.03% 287
2024
Q2 		– Sell
-59,577
Closed -$2.55M – 532
2024
Q1 		$2.55M Buy
59,577
+20,195
+51% +$833K 0.19% 98
2023
Q4 		$1.46M Sell
39,382
-44
-0.1% -$1.58K 0.1% 168
2023
Q3 		$1.43M Sell
39,426
-359
-0.9% -$12.7K 0.1% 160
2023
Q2 		$1.42M Buy
39,785
+10,525
+36% +$378K 0.09% 168
2023
Q1 		$1.04M Buy
+29,260
New +$1.02M 0.08% 228
2022
Q3 		– Sell
-25,169
Closed -$1.37M – 474
2022
Q2 		$1.37M Sell
25,169
-89
-0.4% -$4.91K 0.12% 176
2022
Q1 		$1.38M Sell
25,258
-784
-3% -$42.6K 0.1% 187
2021
Q4 		$1.44M Buy
26,042
+2,171
+9% +$113K 0.09% 193
2021
Q3 		$1.14M Buy
23,871
+1,236
+5% +$62.1K 0.09% 188
2021
Q2 		$1.13M Sell
22,635
-551
-2% -$26.5K 0.07% 214
2021
Q1 		$1.03M Buy
23,186
+1,784
+8% +$81K 0.07% 192
2020
Q4 		$984K Buy
21,402
+4,670
+28% +$215K 0.1% 154
2020
Q3 		$787K Buy
16,732
+238
+1% +$11.9K 0.08% 156
2020
Q2 		$841K Buy
16,494
+3,752
+29% +$192K 0.1% 139
2020
Q1 		$603K Sell
12,742
-2,254
-15% -$120K 0.09% 150
2019
Q4 		$881K Buy
14,996
+1,224
+9% +$68.1K 0.1% 166
2019
Q3 		$735K Buy
13,772
+188
+1% +$9.67K 0.09% 230
2019
Q2 		$680K Buy
+13,584
New +$682K 0.09% 224
2017
Q4 		– Sell
-10,200
Closed -$518K – 264
2017
Q3 		$518K Sell
10,200
-1,496
-13% -$75.9K 0.08% 177
2017
Q2 		$630K Buy
11,696
+1,736
+17% +$92.5K 0.19% 100
2017
Q1 		$525K Buy
+9,960
New +$505K 0.17% 109

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Summit Global Investments's GSK Position: Q2 2026 in Review

Summit Global Investments increased its GSK (GSK) stake by 39% in Q2 2026, buying an estimated $309K and bringing the position to 20,852 shares worth $1.09M. The position accounts for 0.06% of the portfolio, ranked #189.

Summit Global Investments first reported a position in GSK in Q1 2017 and has held it in 24 quarters since. The position peaked at $2.55M in Q1 2024. 475 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Summit Global Investments held 20,852 shares of GSK worth $1.09M as of Q2 2026.
  • Summit Global Investments bought 5,848 GSK shares in Q2 2026, an estimated $309K.
  • GSK made up 0.06% of Summit Global Investments's portfolio in Q2 2026, its #189 holding.
  • Summit Global Investments first reported a position in GSK in Q1 2017 and has held it in 24 quarters since.
  • Summit Global Investments's GSK position peaked at $2.55M in Q1 2024.
  • 475 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.